ELDN logo

Eledon Pharmaceuticals, Inc. (ELDN)

Profile

Full Name

Eledon Pharmaceuticals, Inc.

Ticker

NASDAQ: ELDN

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

September 17, 2014

Indexes

Not included

Website

https://eledon.com

Employees

31

Key Details

Price

$1.55(0.65%)

Market Cap

$116.30M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$0.00(0.00% YoY)

Annual EPS

-$0.75(84.25% YoY)

PE Ratio

-

Next earnings date

Mar 19, 2026

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $1.55
    ELDN price is $1.55

    30-Day Relative Volume

    1.36
    ELDN 30-day relative volume is 1.36

    Price Performance

    Price Most Recent Change

    +0.65%
    ELDN price was up +0.65% on Nov 19, 2025

    Price YTD Change

    -62.38%
    ELDN price is down -62.38% since January 1st

    Price 1-Year Change

    -60.05%
    ELDN price is down -60.05% year-on-year

    Price 3-Year Change

    -41.73%
    ELDN price is down -41.73% over the past 3 years

    Price Range

    Price All-Time High

    $4860.00
    ELDN price is currently -99.97% below its historical high of $4860.00

    Price 3-Year Low

    $1.07
    ELDN price is currently +44.86% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market Cap

    $116.30M
    ELDN market cap is $116.30 million

    Market Cap 3-Year Change

    +217.83%
    ELDN market cap is up +217.83% over the past 3 years

    Market Cap All-Time High

    $518.86M
    ELDN market cap is currently -77.58% below its historical high of $518.86 million

    Market Cap Sector Percentile

    42.34%
    ELDN market cap is higher than 42.34% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +25.6%
    ELDN shares outstanding is up +25.6% year-on-year

    Shares Outstanding 3-Year Change

    +445.43%
    ELDN shares outstanding is up +445.43% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.40
    ELDN beta is 1.40

    200-day SMA

    $3.16
    ELDN price is currently -50.96% below its 200-day simple moving average

    50-day SMA

    $2.86
    ELDN price is currently -45.85% below its 50-day simple moving average

    14-Day RSI

    27.11
    ELDN 14-day relative strength index is 27.11

    Volume

    1.36
    ELDN 30-day relative volume is 1.36

    ATR

    $0.39
    ELDN average true range is $0.39

    10-day Historical Volatility

    253.75%
    ELDN 10-day historical volatility is 253.75%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $0.00
    ELDN annual revenue is $0.00

    Revenue Analysts Estimate

    -
    ELDN annual revenue consensus analysts' forecast is unknown

    Revenue 1-Year Change

    0%
    ELDN annual revenue has remained unchanged year-on-year

    Revenue Sector Percentile

    28.68%
    ELDN annual revenue is higher than 28.68% of companies in Healthcare sector

    EPS

    EPS

    -$0.75
    ELDN annual earnings per share is -$0.75

    EPS Analysts Estimate

    -$0.85
    ELDN annual earnings per share is currently +12.31% higher than the consensus analysts' forecast

    EPS 1-Year Change

    +84.25%
    ELDN annual earnings per share is up +84.25% year-on-year

    EPS Sector Percentile

    61.58%
    ELDN annual earnings per share is higher than 61.58% of companies in Healthcare sector

    Profit

    Gross Profit

    -$359.00K
    ELDN annual gross profit is -$359.00 thousand

    Gross Margin

    -
    ELDN annual gross profit margin value is unknown

    Operating Profit

    -$70.58M
    ELDN annual operating income is -$70.58 million

    Operating Margin

    -
    ELDN annual operating profit margin value is unknown

    Net Income

    -$36.18M
    ELDN annual net profit is -$36.18 million

    Net Margin

    -
    ELDN annual net profit margin value is unknown

    Expenses

    Total Expenses

    $70.58M
    ELDN annual total expenses is $70.58 million

    Operating Expenses

    $70.58M
    ELDN annual total operating expenses is $70.58 million

    Cost Of Goods Sold

    $359.00K
    ELDN annual cost of goods sold is $359.00 thousand

    Selling, General & Administrative Expenses

    $18.61M
    ELDN annual SG&A is $18.61 million

    Depreciation & Amortization

    $359.00K
    ELDN annual D&A is $359.00 thousand

    Interest Expense

    $0.00
    ELDN annual interest expense is $0.00

    Income Tax

    $431.00K
    ELDN annual income tax is $431.00 thousand

    EBIT & EBITDA

    EBIT

    -$70.58M
    ELDN annual earnings before interest & taxes is -$70.58 million

    EBITDA

    -$70.22M
    ELDN annual EBITDA is -$70.22 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total Assets

    $229.44M
    ELDN annual total assets is $229.44 million

    Non Current Assets

    $33.67M
    ELDN annual long term assets is $33.67 million

    Current Assets

    $143.73M
    ELDN annual total current assets is $143.73 million

    Cash and Cash Equivalents

    $20.55M
    ELDN annual cash & cash equivalents is $20.55 million

    Accounts Receivable

    -
    ELDN annual accounts receivable value is unknown

    Inventory

    $0.00
    ELDN annual inventory is $0.00

    Liabilities

    Total Liabilities

    $111.30M
    ELDN annual total liabilities is $111.30 million

    Long Term Liabilities

    $47.69M
    ELDN annual total long term liabilities is $47.69 million

    Current Liabilities

    $11.58M
    ELDN annual current liabilities is $11.58 million

    Accounts Payable

    $5.83M
    ELDN annual accounts payable is $5.83 million

    Debt

    Total Debt

    $954.00K
    ELDN annual total debt is $954.00 thousand

    Total Debt 1-Year Change

    +149.09%
    ELDN annual total debt is up +149.09% year-on-year

    Long Term Debt

    $640.00K
    ELDN annual long term debt is $640.00 thousand

    Short Term Debt

    $314.00K
    ELDN annual short term debt is $314.00 thousand

    Equity & Capital

    Shareholders Equity

    $118.14M
    ELDN annual stockholders equity is $118.14 million

    Book Value

    $118.14M
    ELDN annual book value is $118.14 million

    Retained Earnings

    -$355.59M
    ELDN annual retained earnings is -$355.59 million

    Working Capital

    $132.15M
    ELDN annual working capital is $132.15 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash From Operations

    -$47.27M
    ELDN annual cash from operations is -$47.27 million

    Cash From Operations 1-Year Change

    -19.59%
    ELDN annual cash from operations is down -19.59% year-on-year

    Cash From Investing

    -$70.31M
    ELDN annual cash from investing is -$70.31 million

    Cash From Investing 1-Year Change

    -55.26%
    ELDN annual cash from investing is down -55.26% year-on-year

    Cash From Financing

    $133.52M
    ELDN annual cash from financing is $133.52 million

    Cash From Financing 1-Year Change

    +304.4%
    ELDN annual cash from financing is up +304.4% year-on-year

    CAPEX

    CAPEX

    $0.00
    ELDN annual capital expenditures is $0.00

    CAPEX 1-Year Change

    0%
    ELDN annual capital expenditures has remained unchanged year-on-year

    Free Cash Flow

    Free Cash Flow

    -$47.27M
    ELDN annual free cash flow is -$47.27 million

    Free Cash Flow 1-Year Change

    -19.59%
    ELDN annual free cash flow is down -19.59% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross Margin

    -
    ELDN annual gross profit margin value is unknown

    Operating Margin

    -
    ELDN annual operating profit margin value is unknown

    Net Margin

    -
    ELDN annual net profit margin value is unknown

    ROA & ROE

    ROA

    -20.37%
    ELDN annual return on assets is -20.37%

    ROE

    -57.73%
    ELDN annual return on equity is -57.73%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE Ratio

    -
    ELDN price to earnings ratio value is unknown

    PE Ratio Sector Percentile

    -
    ELDN price to earnings ratio is unknown

    PB Ratio

    PB Ratio

    3.29
    ELDN price to book ratio is 3.29

    PB Ratio Sector Percentile

    65.8%
    ELDN price to book ratio is higher than 65.8% of companies in Healthcare sector

    PS Ratio

    PS Ratio

    -
    ELDN price to sales ratio value is unknown

    PS Ratio Sector Percentile

    -
    ELDN price to sales ratio is unknown

    Enterprise value

    Enterprise Value

    $23.62M
    ELDN enterprise value is $23.62 million

    Enterprise Value Sector Percentile

    28.89%
    ELDN enterprise value is higher than 28.89% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -0.27
    ELDN EV/EBITDA is -0.27

    EV/EBITDA Sector Percentile

    57.19%
    ELDN EV/EBITDA is higher than 57.19% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current Ratio

    12.42
    ELDN annual current ratio is 12.42

    Quick Ratio

    12.42
    ELDN annual quick ratio is 12.42

    Leverage

    Debt To Equity

    0.01
    ELDN annual debt to equity ratio is 0.01

    Interest Coverage Ratio

    -
    ELDN annual interest coverage ratio value is unknown

    Risk & Stability

    F-Score

    -
    ELDN piotroski f-score value is unknown

    Altman Z-Score

    -1.87
    ELDN altman z-score is -1.87

    Analyst ratings

    Recent major analysts updates

    Sep 2, 25 HC Wainwright & Co.
    Buy
    Jul 25, 25 Craig-Hallum
    Buy
    Nov 20, 24 HC Wainwright & Co.
    Buy
    Jun 4, 24 HC Wainwright & Co.
    Buy
    May 10, 24 HC Wainwright & Co.
    Buy
    May 7, 24 HC Wainwright & Co.
    Buy
    Mar 22, 24 HC Wainwright & Co.
    Buy
    Nov 13, 23 HC Wainwright & Co.
    Buy
    Oct 24, 23 HC Wainwright & Co.
    Buy
    Sep 27, 23 Noble Capital Markets
    Outperform

    Institutional Ownership

    Screeners with ELDN included

    Growing Shares Outstanding
    US stocks
    Stocks with high beta
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    • What is the ticker symbol for Eledon Pharmaceuticals, Inc.?
    • Does Eledon Pharmaceuticals, Inc. pay dividends?
    • What sector is Eledon Pharmaceuticals, Inc. in?
    • What industry is Eledon Pharmaceuticals, Inc. in?
    • What country is Eledon Pharmaceuticals, Inc. based in?
    • When did Eledon Pharmaceuticals, Inc. go public?
    • Is Eledon Pharmaceuticals, Inc. in the S&P 500?
    • Is Eledon Pharmaceuticals, Inc. in the NASDAQ 100?
    • Is Eledon Pharmaceuticals, Inc. in the Dow Jones?
    • When was Eledon Pharmaceuticals, Inc.'s last earnings report?
    • When does Eledon Pharmaceuticals, Inc. report earnings?

    What is the ticker symbol for Eledon Pharmaceuticals, Inc.?

    The ticker symbol for Eledon Pharmaceuticals, Inc. is NASDAQ:ELDN

    Does Eledon Pharmaceuticals, Inc. pay dividends?

    No, Eledon Pharmaceuticals, Inc. does not pay dividends

    What sector is Eledon Pharmaceuticals, Inc. in?

    Eledon Pharmaceuticals, Inc. is in the Healthcare sector

    What industry is Eledon Pharmaceuticals, Inc. in?

    Eledon Pharmaceuticals, Inc. is in the Biotechnology industry

    What country is Eledon Pharmaceuticals, Inc. based in?

    Eledon Pharmaceuticals, Inc. is headquartered in United States

    When did Eledon Pharmaceuticals, Inc. go public?

    Eledon Pharmaceuticals, Inc.'s initial public offering (IPO) was on September 17, 2014

    Is Eledon Pharmaceuticals, Inc. in the S&P 500?

    No, Eledon Pharmaceuticals, Inc. is not included in the S&P 500 index

    Is Eledon Pharmaceuticals, Inc. in the NASDAQ 100?

    No, Eledon Pharmaceuticals, Inc. is not included in the NASDAQ 100 index

    Is Eledon Pharmaceuticals, Inc. in the Dow Jones?

    No, Eledon Pharmaceuticals, Inc. is not included in the Dow Jones index

    When was Eledon Pharmaceuticals, Inc.'s last earnings report?

    Eledon Pharmaceuticals, Inc.'s most recent earnings report was on November 14, 2025

    When does Eledon Pharmaceuticals, Inc. report earnings?

    The next expected earnings date for Eledon Pharmaceuticals, Inc. is March 19, 2026
    On this page